These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 6330889

  • 1. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.
    Kalyanaraman VS, Cabradilla CD, Getchell JP, Narayanan R, Braff EH, Chermann JC, Barré-Sinoussi F, Montagnier L, Spira TJ, Kaplan J.
    Science; 1984 Jul 20; 225(4659):321-3. PubMed ID: 6330889
    [Abstract] [Full Text] [Related]

  • 2. Lymphadenopathy associated virus infection of a blood donor--recipient pair with acquired immunodeficiency syndrome.
    Feorino PM, Kalyanaraman VS, Haverkos HW, Cabradilla CD, Warfield DT, Jaffe HW, Harrison AK, Gottlieb MS, Goldfinger D, Chermann JC.
    Science; 1984 Jul 06; 225(4657):69-72. PubMed ID: 6328663
    [Abstract] [Full Text] [Related]

  • 3. Survey of the prevalence of AIDS-associated virus (LAV) infection in Japan.
    Tsuchie H, Kurimura T, Hinuma Y.
    J Infect; 1985 May 06; 10(3):272-6. PubMed ID: 2993425
    [Abstract] [Full Text] [Related]

  • 4. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.
    Klatzmann D, Barré-Sinoussi F, Nugeyre MT, Danquet C, Vilmer E, Griscelli C, Brun-Veziret F, Rouzioux C, Gluckman JC, Chermann JC.
    Science; 1984 Jul 06; 225(4657):59-63. PubMed ID: 6328660
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.
    Casareale D, Dewhurst S, Sonnabend J, Sinangil F, Purtilo DT, Volsky DJ.
    AIDS Res; 1984 Jul 06; 1(6):407-21. PubMed ID: 6085926
    [Abstract] [Full Text] [Related]

  • 6. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
    Neurath AR, Strick N, Sproul P, Baker L, Rubinstein P, Stevens CE, Taylor P, Gallo RC, Gold JW, Lee YS.
    J Virol Methods; 1985 May 06; 11(1):75-86. PubMed ID: 2989312
    [Abstract] [Full Text] [Related]

  • 7. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
    Jaffe HW, Feorino PM, Darrow WW, O'Malley PM, Getchell JP, Warfield DT, Jones BM, Echenberg DF, Francis DP, Curran JW.
    Ann Intern Med; 1985 May 06; 102(5):627-8. PubMed ID: 2984973
    [Abstract] [Full Text] [Related]

  • 8. Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS.
    Barré-Sinoussi F, Mathur-Wagh U, Rey F, Brun-Vezinet F, Yancovitz SR, Rouzioux C, Montagnier L, Mildvan D, Chermann JC.
    JAMA; 1985 May 06; 253(12):1737-9. PubMed ID: 2983130
    [Abstract] [Full Text] [Related]

  • 9. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam.
    Coutinho RA, Krone WJ, Smit L, Albrecht-van Lent P, van der Noordaa J, Schaesberg W, Goudsmit J.
    Genitourin Med; 1986 Feb 06; 62(1):38-43. PubMed ID: 3005159
    [Abstract] [Full Text] [Related]

  • 10. Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.
    Brun-Vezinet F, Rouzioux C, Barre-Sinoussi F, Klatzmann D, Saimot AG, Rozenbaum W, Christol D, Gluckmann JC, Montagnier L, Chermann JC.
    Lancet; 1984 Jun 09; 1(8389):1253-6. PubMed ID: 6144973
    [Abstract] [Full Text] [Related]

  • 11. HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS.
    Tenner-Racz K, Racz P, Bofill M, Schulz-Meyer A, Dietrich M, Kern P, Weber J, Pinching AJ, Veronese-Dimarzo F, Popovic M.
    Am J Pathol; 1986 Apr 09; 123(1):9-15. PubMed ID: 3008562
    [Abstract] [Full Text] [Related]

  • 12. Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state.
    Laurence J, Brun-Vezinet F, Schutzer SE, Rouzioux C, Klatzmann D, Barré-Sinoussi F, Chermann JC, Montagnier L.
    N Engl J Med; 1984 Nov 15; 311(20):1269-73. PubMed ID: 6092953
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.
    Cheingsong-Popov R, Weiss RA, Dalgleish A, Tedder RS, Shanson DC, Jeffries DJ, Ferns RB, Briggs EM, Weller IV, Mitton S.
    Lancet; 1984 Sep 01; 2(8401):477-80. PubMed ID: 6147546
    [Abstract] [Full Text] [Related]

  • 14. [Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type III (LAV/HTLV) in a population of homosexuals in Mexico].
    Sierra Madero JG, Ponce de León S, Ruiz Palacios G, Tinoco JC, Calva JJ, Zamora EE.
    Salud Publica Mex; 1986 Sep 01; 28(2):180-5. PubMed ID: 3014666
    [No Abstract] [Full Text] [Related]

  • 15. Antibody to human T cell leukaemia virus type III in Australian homosexual men with lymphadenopathy.
    Frazer IH, Sarngadharan MG, Mackay IR, Gallo RC.
    Med J Aust; 1984 Sep 01; 141(5):274-6. PubMed ID: 6088957
    [Abstract] [Full Text] [Related]

  • 16. Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes.
    Ellrodt A, Barre-Sinoussi F, Le Bras P, Nugeyre MT, Palazzo L, Rey F, Brun-Vezinet F, Rouzioux C, Segond P, Caquet R.
    Lancet; 1984 Jun 23; 1(8391):1383-5. PubMed ID: 6145837
    [Abstract] [Full Text] [Related]

  • 17. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV, Lewis JH, Bracken M, Toth R, Stokes J, Steffensen DO.
    Transfusion; 1986 Jun 23; 26(3):299-301. PubMed ID: 3010516
    [Abstract] [Full Text] [Related]

  • 18. Radioimmunoassay and enzyme-linked immunoassay of antibodies directed against lymphadenopathy-associated virus (LAV) proteins larger than the core protein (P24).
    Neurath AR, Strick N, Lee YS, Nilsen T, Baker L, Sproul P, Rubinstein P, Taylor P, Stevens CE, Gold JW.
    J Virol Methods; 1985 Oct 23; 12(1-2):85-92. PubMed ID: 3001122
    [Abstract] [Full Text] [Related]

  • 19. Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany.
    Hunsmann G, Schneider J, Bayer H, Kurth R, Werner A, Brede HD, Erfle V, Mellert W, Brodt HR, Bergmann L.
    Klin Wochenschr; 1985 Mar 01; 63(5):233-5. PubMed ID: 2985862
    [Abstract] [Full Text] [Related]

  • 20. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH, Lane HC, Folks T, McCoy S, Alter H, Fauci AS.
    J Immunol; 1987 Feb 15; 138(4):1064-7. PubMed ID: 3027168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.